AC
EVFM

Amici Capital’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Amici Capital’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,047
Closed -$760K – 143
2015
Q3 		$760K Sell
1,047
-2,286
-69% -$2.45M 0.04% 122
2015
Q2 		$2.7M Buy
+3,333
New +$2.14M 0.1% 86

Other funds holding EVFM

CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
AIM
Alambic Investment Management Belvedere, California $9.12M AUM 34.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Virtu KCG Holdings
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Amici Capital's EVFM Position: Q4 2015 in Review

Amici Capital sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q4 2015, closing a stake of 1,047 shares — an estimated $760K sold.

Amici Capital first reported a position in EVFM in Q2 2015 and held it in 2 quarters. The position peaked at $2.7M in Q2 2015. 24 funds tracked by Wall St. Rank hold EVFM as of Q4 2015.

  • Amici Capital reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Amici Capital sold 1,047 Evofem Biosciences, Inc. Common Stock shares in Q4 2015, an estimated $760K.
  • Amici Capital first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2015 and held it in 2 quarters.
  • Amici Capital's Evofem Biosciences, Inc. Common Stock position peaked at $2.7M in Q2 2015.
  • 24 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2015.

Based on Amici Capital's 13F filing for Q4 2015, filed 16 Feb 2016.